HeartCore Enterprises, Inc. (HTCR) has provided an announcement.
HeartCore Enterprises, Inc. has entered into a lucrative consulting agreement with PharmaBio Corporation, marking its thirteenth Go IPO consulting deal. The agreement will see HeartCore generating $800,000 in combined initial and success fees, along with a warrant granting them a 3% ownership stake in PharmaBio’s common stock. This strategic financial move could be a notable point of interest for investors keeping an eye on promising corporate collaborations.
For detailed information about HTCR stock, go to TipRanks’ Stock Analysis page.
